RegisterLogin

Research Grade Nirsevimab

CAT: 1358-VK421026-01Size: 0.1 mgDry Ice: NoHazardous: No
CAT#:1358-VK421026-01Size:0.1 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Product Name Alternative
MEDI-8897, MEDI8897, CAS:1989556-22-0
Expression System
Mammalian Cells
Host
Humanized
Target
F, FusionglycoproteinF0, FusionglycoproteinF2, p27, Interveningsegment, Pep27, Peptide27, FusionglycoproteinF1
Clonality
Monoclonal
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Purification
Protein A/G purified from cell culture supernatant.
Concentration
3.67mg/ml
Endotoxin
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Form
Liquid
Buffer
0.01M PBS, pH7.4.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at4°C short term (1-2weeks) . Store at-20°C 12 months. Store at -590°C long term.
Notes
For research use only. Not suitable for clinical or therapeutic use.
Buffer pH
0.01M PBS, pH7.4.
Species
HRSV-A
Isotype
IgG1, kappa

Related Products

CatalogName
HV571026-01Research Grade Enoticumab
HV571036-01Research Grade Navicixizumab
HV571046-01Research Grade Dilpacimab
HB825026-01Research Grade Mirvetuximab
HV185036-01Research Grade Setrusumab
HC496026-01Research Grade Amatuximab
HX246016-01Research Grade Ensituximab
HB816016-01Research Grade Imalumab
HF574026-01Research Grade Upifitamab
HT020016-01Research Grade Narsoplimab

Alternative Products

CatalogName
MBS1564045-01Research Grade Nirsevimab
DVV02802Research Grade Nirsevimab
ICH5712-50mgNirsevimab Biosimilar - Research Grade
ICH5712-5mgNirsevimab Biosimilar - Research Grade
ICH5712-25mgNirsevimab Biosimilar - Research Grade
ICH5712-20mgNirsevimab Biosimilar - Research Grade
ICH5712-1mgNirsevimab Biosimilar - Research Grade
ICH5712-10mgNirsevimab Biosimilar - Research Grade
10-913Nirsevimab (RSV) - Research Grade Biosimilar
NC294-01RSV Pre-F Antibody (Nirsevimab, Research Grade)

Popular Products